Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The divalent cation binding sites on lipid A phosphate groups are essential structural components of the Gram-negative bacterial outer membrane [1]. These sites consist of negatively charged phosphate moieties located at the 1 and 4' positions of the lipid A anchor of lipopolysaccharide (LPS) [2]. Divalent cations, primarily magnesium (Mg2+) and calcium (Ca2+), bind to these phosphate groups to form ionic bridges that cross-link adjacent LPS molecules [1,2]. This bridging mechanism is vital for neutralizing electrostatic repulsion between the negatively charged LPS molecules, thereby stabilizing the outer membrane and maintaining its role as a robust permeability barrier against toxic substances [2,3]. These binding sites are the primary pharmacological targets for polymyxin antibiotics, such as colistin and polymyxin B [1,4]. Polymyxins act as cationic detergents that competitively displace the divalent cations from the phosphate groups, leading to the destabilization of the outer membrane, increased permeability, and eventual bacterial cell death [1,4]. Understanding these binding sites is also crucial for addressing antibiotic resistance, as many bacteria modify their lipid A phosphate groups to reduce their negative charge and evade drug binding [5].
Competitive displacement of divalent cations (magnesium and calcium) from the phosphate groups of lipid A, leading to the destabilization of the lipopolysaccharide layer, increased membrane permeability, and eventual cell lysis [1, 4].
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lipid A phosphate group divalent cation binding site.